An interventional study of Red cabbage microgreens and Red beet microgreens in Aging, Menopause and Healthy, sponsored by Colorado State University. Completed at 1 site in United States. Open to participants aged 45 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-19.
Sponsored by Colorado State University · Not applicable, Interventional, and Basic science
Microgreens are an emerging horticultural food crop with potential to improve human health. Previous research suggests they have broad consumer acceptance and that the micronutrient and bioactive compound levels are higher than that of their mature counterparts. To date, no studies have explored the feasibility of microgreen consumption, gastrointestinal tolerance of microgreen consumption, or their potential health impacts in humans. Therefore, the overall goal of this study is to explore the feasibility and acceptability of daily microgreen consumption, gastrointestinal tolerability, and potential health impacts of red cabbage and red beet microgreens in healthy middle-aged/older men and postmenopausal women - a population inherently at risk for chronic disease, e.g. cardiovascular disease.
Colorado State University is the lead sponsor of 116 studies on the registry; 20 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
2 cups of fresh red cabbage microgreens per day
Other: Red cabbage microgreens
2 cups of fresh red beet microgreens per day
Other: Red beet microgreens
2 cups per day
2 cups per day
Number of participants retained
The number of participants retained versus lost to follow-up throughout the entire study
Time frame: Baseline to 6 weeks
Adherence to the intervention
Adherence will be determined for each 2-week microgreen intervention through a daily microgreen consumption log
Time frame: Baseline to 2 weeks
Gastrointestinal symptom self-assessment
Determine the effects on gastrointestinal symptoms using a validated questionnaire for each 2-week microgreen intervention
Time frame: Baseline to 2 weeks
Gastrointestinal health
Determine the effects on gastrointestinal health using a daily bowel movement log for each 2-week microgreen intervention
Time frame: Baseline to 2 weeks
Blood pressure
Determine the effects on brachial and aortic blood pressure measured by SphygmoCor for each 2-week microgreen intervention
Time frame: Baseline to 2 weeks
Augmentation index
Determine the effects on augmentation index measured by SphygmoCor for each 2-week microgreen intervention
Time frame: Baseline to 2 weeks
Microbiota modulation
Use of 16s rRNA sequencing of stool samples to determine the effects of each 2-week microgreen intervention on microbial populations
Time frame: Baseline to 2 weeks
Acceptability
Determine acceptability and feasibility of daily microgreen consumption through qualitative interviews with study participants at completion of the 2-week study
Time frame: 2-week visit
Changes in plasma metabolites
Use of mass spectrometry to determine the effects on plasma metabolites of bioactive compounds for each 2-week microgreen intervention
Time frame: Baseline to 2 weeks
This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.